{"id":"W3000081647","doi":"10.1080/19420862.2019.1709322","title":"VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Monoclonal antibody; Chemokine; Antagonist; Chemokine receptor; Inflammation; Pharmacology; Antibody; CX3CR1; Dosing; CCR5 receptor antagonist; Medicine; Immunology; Receptor; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002371124,0.0001433915,0.0003020041,0.00002379931,0.00008175927,0.00001430886,0.0001072387,0.00008098153,0.000718118],"category_scores_gemma":[0.0002317617,0.00008794993,0.0001318363,0.0003121551,0.00006779122,0.00004136363,0.00009283668,0.0002179596,0.00003796288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002190989,"about_ca_system_score_gemma":0.00003534917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009601635,"about_ca_topic_score_gemma":1.892337e-7,"domain_scores_codex":[0.9988838,0.00003114995,0.0003259091,0.0002302991,0.0003246844,0.0002041068],"domain_scores_gemma":[0.9994079,0.00005043753,0.0001441723,0.0001673219,0.0001112647,0.0001188431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009346067,0.00007016896,0.01909588,0.0001818942,0.00002697561,9.197078e-7,0.0008529537,0.000002823093,0.9685293,0.00002660551,0.004500088,0.006618949],"study_design_scores_gemma":[0.0009808763,0.0002580154,0.001818407,0.000431697,0.00004791468,0.000002768996,0.0003207399,0.000511775,0.9678355,0.000007069193,0.0276694,0.0001158191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988418,0.0005609274,0.0001769454,0.009472065,0.0001045667,0.0003324794,0.000006717977,0.00007277987,0.0008555586],"genre_scores_gemma":[0.9972605,0.0001477962,0.001186837,0.0006311817,0.0005592656,0.00000897736,0.00005970771,0.00003225804,0.0001135124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02316931,"threshold_uncertainty_score":0.7862888,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02458433497212176,"score_gpt":0.2955950948267394,"score_spread":0.2710107598546176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}